SCHEDULE 13D

Company

TherapeuticsMD, Inc.

Filed

June 26, 2008

Accession Number

0001019687-08-002823

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →